KANAPH Therapeutics

Leader of next generation immuno-oncology and autoimmune therapies

Seoul, South Korea · Founded 2019 · $25.4M raised

Headquarters
Seoul
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$25.4M
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds for this company. The full record is or through the API.

About

KANAPH Therapeutics is a South Korean drug discovery and pre-clinical stage biotech company founded in February 2019, with its name derived from the Hebrew word for 'healing wings.' Headquartered in Seoul, the company pursues a dual large- and small-molecule strategy to develop first-in-class and best-in-class therapeutics for immuno-oncology, targeted therapy, and autoimmune (ophthalmology) diseases. Its oncology pipeline features bispecific antibodies and small molecules targeting the tumor microenvironment (TME), while its autoimmune pipeline includes bispecific Fc-fusions that inhibit the alternative complement pathway. KANAPH has filed for a KOSDAQ listing and raised over KRW 24 billion in funding.

Summary

KANAPH Therapeutics is a Biotech company based in Seoul, South Korea, founded in 2019. It has raised $25.4M in total across 3 rounds.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries B
$17.4M

Sign up to see all 3 events

Funding, valuations, and company events, with amounts and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

KANAPH Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/kanaph-therapeutics"><img src="https://indexed.vc/api/badge/company/kanaph-therapeutics" alt="KANAPH Therapeutics on Indexed.vc" width="260" height="76" /></a>